Catalysts
PRVA Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
PRVA
CatalystsStock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 25/100 and sentiment — before the next covered event.
Updated Sep 6, 2026 · Sentiment 7.01%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | — | $0.07 | $0.07 | +3.9% | $597.33M | $632.63M |
| May 7, 2026 | — | $0.08 | $0.02 | -75.0% | $560.99M | $603.85M |
| Feb 26, 2026 | — | $0.04 | $0.07 | +75.0% | $516.15M | $541.17M |
| Nov 6, 2025 | — | $0.06 | $0.05 | -16.7% | $516.61M | $580.42M |
| Aug 7, 2025 | — | $0.05 | $0.02 | -60.0% | $485.56M | $521.15M |
| May 8, 2025 | — | $0.06 | $0.03 | -50.0% | $458.57M | $480.1M |
| Feb 27, 2025 | — | $0.05 | $0.03 | -40.0% | $480.52M | $460.9M |
| Nov 7, 2024 | — | $0.05 | $0.03 | -40.0% | $420.52M | $437.92M |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
Privia Health Group Q2 Earnings Call Highlights
Privia Health Group (NASDAQ:PRVA) reported second-quarter results marked by double-digit growth in implemented providers, attributed lives and practice collections, while adjusted EBITDA rose 29% from a year earlier. Management also raised its 2026 outlook for several financial measures following wh
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Related Links
PRVA Catalysts FAQ
What are the next catalysts for PRVA stock?
PRVA's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move PRVA stock?
Upcoming events that could move PRVA include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could PRVA's next earnings report affect the stock?
PRVA's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive PRVA stock higher?
PRVA could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt PRVA stock?
PRVA could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.